Kathryn E Weaver

Kathryn E Weaver

Wake Forest University

H-index: 40

North America-United States

About Kathryn E Weaver

Kathryn E Weaver, With an exceptional h-index of 40 and a recent h-index of 31 (since 2020), a distinguished researcher at Wake Forest University, specializes in the field of Cancer Survivorship, Cancer Care Delivery.

His recent articles reflect a diverse array of research interests and contributions to the field:

Abstract PO1-12-11: How do chemotherapy and age affect physical performance in breast cancer patients over 12 months of treatment? Results from the UPBEAT Study (UPBEAT WF-97415)

CHANGES IN SKELETAL MUSCLE QUALITY DURING RECEIPT OF ANTHRACYCLINE-BASED CHEMOTHERAPY

ASSOCIATION OF INTERMUSCULAR FAT AND PHYSICAL ACTIVITY LEVELS ON EXERCISE CAPACITY IN BREAST CANCER SURVIVORS (WF-97415)

DECREASED HDL IS ASSOCIATED WITH REDUCED LVEF DURING BREAST CANCER TREATMENT

A Pilot Study of Carotid Ultrasound to Identify Head and Neck Cancer Survivors with High Cardiovascular Risk after Radiation Therapy

Biomarkers associated with atherosclerosis-related cardiovascular dysfunction in cancer survivors treated with anthracyclines

Availability of cancer survivorship support services across the National Cancer Institute Community Oncology Research Program network

Processes for identifying caregivers and screening for caregiver and patient distress in community oncology: results from WF-1803CD

Kathryn E Weaver Information

University

Position

Wake Forest School of Medicine

Citations(all)

5944

Citations(since 2020)

3269

Cited By

4060

hIndex(all)

40

hIndex(since 2020)

31

i10Index(all)

68

i10Index(since 2020)

61

Email

University Profile Page

Google Scholar

Kathryn E Weaver Skills & Research Interests

Cancer Survivorship

Cancer Care Delivery

Top articles of Kathryn E Weaver

Abstract PO1-12-11: How do chemotherapy and age affect physical performance in breast cancer patients over 12 months of treatment? Results from the UPBEAT Study (UPBEAT WF-97415)

Cancer Research

2024/5/2

CHANGES IN SKELETAL MUSCLE QUALITY DURING RECEIPT OF ANTHRACYCLINE-BASED CHEMOTHERAPY

Journal of the American College of Cardiology

2024/4/2

Kathryn E Weaver
Kathryn E Weaver

H-Index: 24

ASSOCIATION OF INTERMUSCULAR FAT AND PHYSICAL ACTIVITY LEVELS ON EXERCISE CAPACITY IN BREAST CANCER SURVIVORS (WF-97415)

Journal of the American College of Cardiology

2024/4/2

DECREASED HDL IS ASSOCIATED WITH REDUCED LVEF DURING BREAST CANCER TREATMENT

Journal of the American College of Cardiology

2024/4/2

A Pilot Study of Carotid Ultrasound to Identify Head and Neck Cancer Survivors with High Cardiovascular Risk after Radiation Therapy

International Journal of Radiation Oncology, Biology, Physics

2024/4/1

Biomarkers associated with atherosclerosis-related cardiovascular dysfunction in cancer survivors treated with anthracyclines

Cancer Research

2024/3/22

Availability of cancer survivorship support services across the National Cancer Institute Community Oncology Research Program network

JNCI Cancer Spectrum

2024/2/1

Jamie M Faro
Jamie M Faro

H-Index: 3

Kathryn E Weaver
Kathryn E Weaver

H-Index: 24

Processes for identifying caregivers and screening for caregiver and patient distress in community oncology: results from WF-1803CD

JNCI: Journal of the National Cancer Institute

2024/2/1

Kathryn E Weaver
Kathryn E Weaver

H-Index: 24

Cardiovascular health assessment in routine cancer follow-up in community settings: survivor risk awareness and perspectives

BMC cancer

2024/1/31

Endometrial cancer survivors' perceptions of their cardiovascular disease risk (results from WF-1804CD AH-HA)

Gynecologic oncology

2023/7/1

Effectiveness of a cardiovascular health EHR application for cancer survivors in community oncology practice: Results from WF-1804CD.

2023/6/10

Atorvastatin Does Not Attenuate Aortic Stiffening After Doxorubicin for Breast Cancer and Lymphoma (PREVENT-WF-98213)

Cardio Oncology

2023/6/1

Kathryn E Weaver
Kathryn E Weaver

H-Index: 24

Availability of palliative specialty care for adults in community oncology: Results from the 2022 NCORP landscape assessment.

2023/6/1

Phase 3 randomized placebo-controlled trial of donepezil for late cancer-related cognitive impairment in breast cancer survivors exposed to chemotherapy from the Wake Forest …

2023/6/1

Emily Van Meter Dressler
Emily Van Meter Dressler

H-Index: 15

Kathryn E Weaver
Kathryn E Weaver

H-Index: 24

Sexual orientation and gender identity data collection among NCI community oncology research program (NCORP) practices: A 5-year landscape update.

2020/7

Cost and time estimates for integrating a cardiovascular health application for cancer survivors in the electronic health record: Case studies from the NCORP network.

2023/6/1

Brian J Wells
Brian J Wells

H-Index: 20

Kathryn E Weaver
Kathryn E Weaver

H-Index: 24

The 2022 NCI Community Oncology Research Program (NCORP) Landscape Committee Assessment: Methods and participating practice group characteristics.

2023/6/1

Pilot study of implementing the Shared Healthcare Actions & Reflections Electronic systems in Survivorship (SHARE‐S) program in coordination with clinical care

Cancer Medicine

2023/6

Kavitha Balakrishnan
Kavitha Balakrishnan

H-Index: 4

Kathryn E Weaver
Kathryn E Weaver

H-Index: 24

Prognostic awareness, palliative care use, and barriers to palliative care in patients undergoing immunotherapy or chemo-immunotherapy for metastatic lung cancer

Journal of Palliative Medicine

2023/6/1

Kathryn E Weaver
Kathryn E Weaver

H-Index: 24

Intermuscular Fat Changes Are Related to Reduced Left Ventricular Ejection Fraction During Cancer Therapy (PREVENT-WF-98213)

Cardio Oncology

2023/6/1

Kathryn E Weaver
Kathryn E Weaver

H-Index: 24

See List of Professors in Kathryn E Weaver University(Wake Forest University)

Co-Authors

academic-engine